CS Diagnostics (CSDX) Stock Statistics & Valuation Metrics

CS Diagnostics has a market cap or net worth of $32.69M. The enterprise value is $59.50M.

CS Diagnostics has 137,340,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

CS Diagnostics’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is >-0.01%.

The current PE Ratio of CS Diagnostics is 2350.0. CS Diagnostics’s PEG ratio is 0.00.

In the last 12 months, CS Diagnostics had revenue of 126.04K and earned -22.00K in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was 99.42K and capital expenditures 499.44M, giving a free cash flow of 499.54M billion.

CS Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―

CS Diagnostics upcoming earnings date is ―, ―.

CS Diagnostics as a current ratio of ―, with Debt / Equity ratio of 0.00%

In the past 12 months, CS Diagnostics has paid 0.00 in taxes.

CS Diagnostics EV to EBITDA ratio is -2.52K, with an EV/FCF ratio of -0.11.

CS Diagnostics has $13.00 in cash and marketable securities with $0.00 in debt, giving a net cash position of $13.00 billion.

Gross margin is 96.93%, with operating margin of ―, and net profit margin of ―.

The average price target for CS Diagnostics is ―, which is 11.43% higher than the current price. The consensus rating is ―